Stanislav Glezer
Chief Tech/Sci/R&D Officer presso INOGEN, INC.
Patrimonio netto: 129 975 $ in data 31/03/2024
Profilo
Il dottor Stanislav Glezer è Chief Medical Officer & Executive Vice President presso Inogen, Inc. e Worldwide Vice President-Medical Affairs presso Becton, Dickinson & Co. Fa parte del consiglio di amministrazione della Diabetes Foundation of New Jersey. Il Dr. Glezer è stato precedentemente impiegato come Chief Medical Officer presso Adocia SA e come Vice Presidente-Global Medical Affairs presso Novo Nordisk, Inc. Ha ricevuto il suo MBA dalla California Coast University e un dottorato dalla Yevdokimov MSUMD.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INOGEN, INC.
0.07% | 01/03/2024 | 16 106 ( 0.07% ) | 129 975 $ | 31/03/2024 |
Posizioni attive di Stanislav Glezer
| Società | Posizione | Inizio |
|---|---|---|
| INOGEN, INC. | Chief Tech/Sci/R&D Officer | 21/06/2021 |
| Diabetes Foundation of New Jersey | Director/Board Member | 24/07/2019 |
Precedenti posizioni note di Stanislav Glezer
| Società | Posizione | Fine |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Chief Tech/Sci/R&D Officer | 01/06/2021 |
| ADOCIA | Chief Tech/Sci/R&D Officer | 01/05/2018 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Chief Tech/Sci/R&D Officer | 01/03/2017 |
| Sanofi SA | Corporate Officer/Principal | - |
Formazione di Stanislav Glezer
| California Coast University | Masters Business Admin |
| Yevdokimov MSUMD | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| INOGEN, INC. | Health Technology |
| ADOCIA | Health Technology |
| Aziende private | 3 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Sanofi SA | Health Technology |
| Diabetes Foundation of New Jersey |
- Borsa valori
- Insiders
- Stanislav Glezer
